Elestat Related Published Studies
Well-designed clinical trials related to Elestat (Epinastine Ophthalmic)
Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. [2009.08]
Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. [2008.07.08]
An open-label, investigator-masked, crossover study of the ocular drying effects of two antihistamines, topical epinastine and systemic loratadine, in adult volunteers with seasonal allergic conjunctivitis. [2007.04]
Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model. [2004.08]
Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis. [2004.01]
Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis. [2004.01]
Well-designed clinical trials possibly related to Elestat (Epinastine Ophthalmic)
Treatment of allergic conjunctivitis: results of a 1-month, single-masked randomized study. [2010.09]
Other research related to Elestat (Epinastine Ophthalmic)
Epinastine: topical ophthalmic second generation antihistamine without significant systemic side effects. [2009.09]
Epinastine 0.05% ophthalmic solution in contact lens-wearing subjects with a history of allergic conjunctivitis. [2009.01]
Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge. [2007.06]
Effects of topical anti-inflammatory agents in a botulinum toxin B-induced mouse model of keratoconjunctivitis sicca. [2007.02]
Effect of topical ophthalmic epinastine and olopatadine on tear volume in mice. [2006.12]
Other possibly related research studies
Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis. [2005]
Duration of action of topical antiallergy drugs in a Guinea pig model of histamine-induced conjunctival vascular permeability. [2007.08]
Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo. [2007.11]
Ocular comfort and drying effects of three topical antihistamine/mast cell stabilizers in adults with allergic conjunctivitis: a randomized, double-masked crossover study. [2008.07]
Multiple action agents and the eye: do they really stabilize mast cells? [2009.10]
Treatment of allergic conjunctivitis: results of a 1-month, single-masked
randomized study. [2010]
|
